Mifegest 200 mg Tablet

About Mifegest 200 mg Tablet

Mifegest 200 mg is a tablet from Radiant Pharmaceuticals Ltd., with the generic name Mifepristone. Another use is labour induction for expulsion of a dead fetus.

There are 6 brands of Mifepristone listed in Bangladesh. The lowest listed price is MIF 200 mg Tablet at ৳ 175.00 per unit.

What is Mifegest 200 mg Tablet?

Made by Radiant Pharmaceuticals Ltd., Mifegest 200 mg is a tablet whose active ingredient is Mifepristone. The medicine is used as part of medical pregnancy termination, to soften and dilate the cervix before surgical termination, to prepare for prostaglandin analogues, and to induce labour when there is fetal death in utero. An ultrasound scan and/or a beta-hCG measurement must be done before it is administered. Ask your doctor or pharmacist if you are unsure about it.

Uses of Mifegest 200 mg

Another use is labour induction for expulsion of a dead fetus. It is also used for labour induction to expel a dead fetus. Mifegest 200 mg is used as a medical alternative to surgical termination of an intra-uterine pregnancy, to soften and dilate the cervix before surgical termination, and to prepare the uterus for the action of prostaglandin analogues in medical pregnancy termination. The doctor decides whether it is suitable for a particular person after proper assessment.

How to use Mifegest 200 mg

Mifegest 200 mg is a tablet that must be taken under the supervision of a qualified physician, and it is supplied only in single-dose packaging. Swallow the tablet with water. Mifegest 200 mg is taken by mouth. Complete the course exactly as prescribed. The doctor decides the dose and course, including whether another medicine is needed afterwards and when follow-up should happen.

Side effects of Mifegest 200 mg

Bleeding increases with gestational age; heavy bleeding happens in some cases and may require a procedure to stop it. Seek medical help promptly if bleeding is heavy or you feel unwell. Uterine contractions or cramping are common in the hours after prostaglandin intake. Contact your doctor if you notice anything unusual after taking it. Contact your doctor promptly if bleeding is heavy, you feel faint, or you have severe pain, fever or an unusual reaction.

Safety and precautions

It must not be given to people with chronic adrenal failure, allergy to Mifepristone or any ingredient, severe asthma not controlled by corticosteroid therapy, or porphyrias. Mifegest 200 mg 200 mg tablet must be given only under a qualified doctor's supervision. An ultrasound scan and/or a beta-hCG test is needed before it is given, to confirm the pregnancy and its age and to rule out an extra-uterine pregnancy. Keep out of reach of children.

Frequently asked questions

What is Mifegest 200 mg used for?

Another use is labour induction for expulsion of a dead fetus. It is also used for labour induction to expel a dead fetus.

How should I take Mifegest 200 mg?

Mifegest 200 mg is a tablet that must be taken under the supervision of a qualified physician, and it is supplied only in single-dose packaging. Swallow the tablet with water.

What should I watch for while using Mifegest 200 mg?

Bleeding increases with gestational age; heavy bleeding happens in some cases and may require a procedure to stop it. Seek medical help promptly if bleeding is heavy or you feel unwell.

Is Mifegest 200 mg safe for everyone?

It must not be given to people with chronic adrenal failure, allergy to Mifepristone or any ingredient, severe asthma not controlled by corticosteroid therapy, or porphyrias. Mifegest 200 mg 200 mg tablet must be given only under a qualified doctor's supervision.

Indications

Mifepristone is indicated:
  • As a medical alternative to surgical termination of intra-uterine pregnancy
  • Softening and dilatation of the cervix uteri prior to surgical pregnancy termination
  • Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reasons
  • Labour induction for the expulsion of a dead fetus (fetal death in utero).

Pharmacology

Mifepristone is a synthetic steroid which blocks the effects of progesterone by competitively binding to the intracellular progesterone receptor. It sensitises the myometrium to the contraction-inducing action of prostaglandin. At higher doses, it blocks the effect of cortisol at the glucocorticoid receptor while increasing circulating cortisol concentrations.

Dosage & Administration

As a medical alternative to surgical termination of intra-uterine pregnancy in early pregnancy: 600 mg Mifepristone in a single oral dose followed 36-48 hrs later, by the administration of a prostaglandin analogue Misoprostol 400 mcg orally (up to 49 days) or Gemeprost 1 mg vaginally (up to 63 days). 

Softening and dilatation of the cervix uteri prior to surgical pregnancy termination: 200 mg Mifepristone, followed 36-48 hrs later (but not beyond) by a surgical termination of pregnancy. 

Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reasons (to reduce the doses of prostaglandin): 600 mg of Mifepristone taken in a single oral dose, 36-48 hrs prior to scheduled prostaglandin administration which will be repeated as often as indicated. 

Labour induction for expulsion of a dead fetus (fetal death in utero): 600 mg of Mifepristone in a single oral daily dose for 2 consecutive days. Mifepristone alone leads to expulsion in about 60%. Labour should be induced by the usual methods if it has not started within 72 hrs following the first administration of Mifepristone.

Interaction

ketoconazole, itraconazole, erythromycin and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone). Furthermore, rifampicin, dexamethasone, St John's Wort and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of Mifepristone). Based on invitro inhibition information, co-administration of mifepristone may lead to an increase in serum levels of drugs that are CYP3A4 substrates.

Limited evidence suggests that co-administration of NSAIDs on the day of prostaglandin administration does not adversely influence the effects of Mifepristone or the prostaglandin on cervical ripening or uterine contractility and does not reduce the clinical efficacy of medical termination of pregnancy.

Contraindications

Mifepristone must not be administered if there is doubt as to the existence or age of the pregnancy or if an extra-uterine pregnancy is suspected. An ultrasound scan and/or measurement of Beta-hCG must be performed before administration. For first trimester abortions, Mifepristone is contraindicated if the pregnancy is beyond 49 days of amenorrhoea when used with Misoprostol, or beyond 63 days of amenorrhoea when used with Gemeprost. Mifepristone should never be prescribed in patients with chronic adrenal failure, known allergy to Mifepristone or to any component of the product, severe asthma uncontrolled by corticosteroid therapy, porphyrias and renal failure, liver failure or malnutrition, or during breast feeding. Mifepristone is a lipophilic compound and may theoretically be excreted in the mother\'s breast milk, however no data is available.

Side Effects

It is very common for women to experience uterine contractions or cramping (10-45%) in the hours following prostaglandin intake. Bleeding increases with gestational age. Heavy bleeding occurs in about 5% of cases and from 0-1.4% may require haemostatic curettage. Uterine rupture, hypotension, skin rashes, urticaria, hot flashes and dizziness have been uncommonly reported.

Pregnancy & Lactation

Pregnancy: Mifepristone is indicated for use in the termination of pregnancy (through 49 days’ pregnancy) and has no other approved indication for use during pregnancy.

Lactation: It is not known whether Mifepristone is excreted in human milk. Many hormones with a similar chemical structure, however, are excreted in breast milk. Since the effects of Mifepristone on infants are unknown, breast-feeding women should consult with their health care provider to decide if they should discard their breast milk for a few days following administration of the medications.

Precautions & Warnings

Mifepristone is available only in single dose packaging. Administration must be under the supervision of a qualified physician. There are no data on the safety and efficacy of Mifepristone in women with chronic medical conditions such as cardiovascular, hypertensive, hepatic, respiratory or renal disease; insulin-dependent diabetes mellitus; severe anemia or heavy smoking. Women who are more than 35 years of age and who also smoke 10 or more cigarettes per day should be treated with caution because such patients were generally excluded from clinical trials of Mifepristone. Although there is no clinical evidence, the effectiveness of Mifepristone may be lower if Misoprostol is administered more than two days after Mifepristone administration.

Overdose Effects

Single doses of Mifepristone up to 2 gm caused no unwanted reaction. In the event of massive ingestion, signs of adrenal failure might occur. Acute intoxication may require admission to hospital and if relevant treatment with dexamethasone.

Alternative brands of Mifepristone

Other brands with the same generic name, cheapest first.

MIF Tablet

200 mg

Mifepristone

Renata PLC.

৳ 171.5 ৳ 175.00 2% off per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.